Adult patients harbouring IDH mutated low-grade glioma have a better prognosis than IDH-WT tumors after extensive tumor resection [2] and can therefore dedicate, if required, a longer time in rehabilitation after surgery before eventual adjuvant therapy. The gene discussed is IDH2; the disease is central nervous system cancer.